期刊
JOURNAL OF VIROLOGY
卷 74, 期 23, 页码 11422-11425出版社
AMER SOC MICROBIOLOGY
DOI: 10.1128/JVI.74.23.11422-11425.2000
关键词
-
类别
资金
- NCI NIH HHS [CA70071] Funding Source: Medline
- NIAID NIH HHS [AI30731, P01 AI030731] Funding Source: Medline
We used CD4 lymphocyte clones from herpes simplex virus type 2 (HSV-2) lesions or the cervix and molecular libraries of HSV-2 DNA to define HSV-2 major capsid protein VP5 and glycoprotein E (gE) as T-cell antigens. Responses to eight HSV-2 glycoprotein, tegument, nonstructural, or capsid antigens were compared in 19 donors. Recognition of VP5 and tegument VP22 were similar to that of gB2 and gD2, currently under study as vaccines. These prevalence data suggest that HSV capsid and tegument proteins may also be candidate vaccine antigens.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据